In vitro effect of free and complexed indium(III) against Mycobacterium tuberculosis

被引:28
作者
David, S
Barros, V
Cruz, C
Delgado, R
机构
[1] Univ Nova Lisboa, Inst Higene & Med Trop, Mycobacteriol Unit, P-1349008 Lisbon, Portugal
[2] UNL, Inst Tecnol Quim & Biol, P-2781901 Oeiras, Portugal
[3] Inst Super Tecn, P-1049001 Lisbon, Portugal
关键词
Mycobacterium tuberculosis; macrocyclic compounds; metal complexes;
D O I
10.1016/j.femsle.2005.07.044
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
In mycobacteria, the study of inhibition by metal ions has been limited by the absence of suitable molecular vectors. Recently, we reported on the inhibitory activity of a family of chelators, macrocyclic compounds (MCC), against Mycobacterium tuberculosis. In this study equimolar concentrations of the free cations vanadium(IV), arsenic(III), iron(III), indium(III) and bismuth(III), and as 1: 1 complexes with the MCC 1,418,11-tetraazacyclotetradecane- 1,4,8,11-tetra-acetic acid (TETA) were tested in vitro against M. tuberculosis using the Bactec (TM) 460 TB radiometric technology (Becton-Dickinson, MD, USA). Radiometric inhibition above 80% was obtained with free indium(III) and bismuth(III), and ranged from 80% to 99%, with the complexes of TETA with vanadium(IV), bismuth(III) and indium(III), in the order of increasing activity. The highest radiometric inhibition levels were obtained with the [ln(TETA)](-) complex, which caused drops of up to 4 log units in cellular viability. The minimal inhibitory concentration of this compound was evaluated at 3 mu M. (c) 2005 Federation of European Microbiological Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:119 / 124
页数:6
相关论文
共 42 条
[1]   Principles and recent developments in chelation treatment of metal intoxication [J].
Andersen, O .
CHEMICAL REVIEWS, 1999, 99 (09) :2683-2710
[2]   Radiometal labeled agents (non-technetium) for diagnostic imaging [J].
Anderson, CJ ;
Welch, MJ .
CHEMICAL REVIEWS, 1999, 99 (09) :2219-2234
[3]   COMPLEXES OF MYCOBACTIN FROM MYCOBACTERIUM-SMEGMATIS WITH SCANDIUM, YTTRIUM AND LANTHANUM [J].
ANDRES, Y ;
MACCORDICK, HJ ;
HUBERT, JC .
BIOLOGY OF METALS, 1991, 4 (04) :207-210
[4]  
BARCLAY R, 1986, ZBL BAKT-INT J MED M, V262, P203
[5]   Vanadium interferes with siderophore-mediated iron uptake in Pseudomonas aeruginosa [J].
Baysse, C ;
De Vos, D ;
Naudet, Y ;
Vandermonde, A ;
Ochsner, U ;
Meyer, JM ;
Budzikiewicz, H ;
Schäfer, M ;
Fuchs, R ;
Cornelis, P .
MICROBIOLOGY-UK, 2000, 146 :2425-2434
[6]   The history of gold therapy for tuberculosis [J].
Benedek, TG .
JOURNAL OF THE HISTORY OF MEDICINE AND ALLIED SCIENCES, 2004, 59 (01) :50-89
[7]   A SIMPLE AND RELIABLE EDDA METHOD FOR MYCOBACTIN PRODUCTION IN MYCOBACTERIA - OPTIMAL CONDITIONS AND USE IN MYCOBACTERIAL SPECIATION [J].
BOSNE, S ;
PAPA, F ;
CLAVELSERES, S ;
RASTOGI, N .
CURRENT MICROBIOLOGY, 1993, 26 (06) :353-358
[8]   Evaluation of growth promotion and inhibition from mycobactins and nonmycobacterial siderophores (Desferrioxamine and FR160) in Mycobacterium aurum [J].
BosneDavid, S ;
Bricard, L ;
Ramiandrasoa, F ;
DeRoussent, A ;
Kunesch, G ;
Andremont, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (08) :1837-1839
[9]   Nickel(II) 2,6-diacetylpyridine bis(isonicotinoylhydrazonate) and bis(benzoylhydrazonate) complexes:: Structure and antimycobacterial evaluation.: Part XI [J].
Bottari, B ;
Maccari, R ;
Monforte, F ;
Ottanà, R ;
Vigorita, MG ;
Bruno, G ;
Nicolò, F ;
Rotondo, A ;
Rotondo, E .
BIOORGANIC & MEDICINAL CHEMISTRY, 2001, 9 (08) :2203-2211
[10]   Antimycobacterial in vitro activity of cobalt(II) isonicotinoylhydrazone complexes.: Part 10 [J].
Bottari, B ;
Maccari, R ;
Monforte, F ;
Ottanà, R ;
Rotondo, E ;
Vigorita, MG .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (03) :301-303